Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Revenue (2016 - 2022)

Historic Revenue for Aptevo Therapeutics (APVO) over the last 8 years, with Q1 2022 value amounting to $3.1 million.

  • Aptevo Therapeutics' Revenue rose 2862.45% to $3.1 million in Q1 2022 from the same period last year, while for Dec 2022 it was $3.1 million, marking a year-over-year decrease of 7466.64%. This contributed to the annual value of $3.1 million for FY2022, which is 7466.64% down from last year.
  • Latest data reveals that Aptevo Therapeutics reported Revenue of $3.1 million as of Q1 2022, which was up 2862.45% from $3.7 million recorded in Q4 2021.
  • Aptevo Therapeutics' Revenue's 5-year high stood at $9.0 million during Q4 2019, with a 5-year trough of $473000.0 in Q2 2020.
  • In the last 5 years, Aptevo Therapeutics' Revenue had a median value of $3.7 million in 2021 and averaged $4.6 million.
  • Per our database at Business Quant, Aptevo Therapeutics' Revenue plummeted by 9357.34% in 2020 and then skyrocketed by 55750.53% in 2021.
  • Aptevo Therapeutics' Revenue (Quarter) stood at $5.8 million in 2018, then skyrocketed by 55.07% to $9.0 million in 2019, then tumbled by 73.72% to $2.4 million in 2020, then surged by 54.45% to $3.7 million in 2021, then decreased by 15.03% to $3.1 million in 2022.
  • Its last three reported values are $3.1 million in Q1 2022, $3.7 million for Q4 2021, and $3.1 million during Q3 2021.